Grau C
Kraeftens Bekaempelses afdeling for eksperimental klinisk onkologi, Arhus.
Ugeskr Laeger. 1993 Jan 25;155(4):208-11.
The current clinical and biological knowledge about radiation myelopathy is reviewed. Transient myelopathy with Lhermitte's sign develops within months after irradiation. Symptoms generally disappear within months without treatment. Chronic progressive radiation myelopathy develops with a latency of several months to years after spinal cord irradiation. The symptoms are paraesthesia, paresis or paralysis, leading to severe physical disability and eventually death due to secondary infections. The long term survival after myelopathy is 30% for cervical myelopathy and 70% for thoracic myelopathy. There is no effective treatment. Analysis of clinical reports shows that the risk of developing chronic myelopathy is less than 2% after 55 Gy, given in 2 Gy daily fractions. Other important radiobiological risk factors (dose per fraction, interfraction interval and volume) are discussed.
本文综述了目前关于放射性脊髓病的临床和生物学知识。伴有莱尔米特征的短暂性脊髓病在放疗后数月内出现。症状通常在未经治疗的情况下数月内消失。慢性进行性放射性脊髓病在脊髓照射后数月至数年的潜伏期后出现。症状为感觉异常、轻瘫或瘫痪,导致严重身体残疾,最终因继发感染死亡。脊髓病后的长期生存率,颈段脊髓病为30%,胸段脊髓病为70%。目前尚无有效治疗方法。对临床报告的分析表明,每日分次给予2Gy,55Gy后发生慢性脊髓病的风险低于2%。文中还讨论了其他重要的放射生物学危险因素(分次剂量、分次间隔和体积)。